UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of May
2025
Commission File Number: 001-41411
Haleon plc
(Translation
of registrant’s name into English)
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F:
|
|
Form
20-F ☒
|
Form
40-F ☐
|
|
EXHIBIT INDEX
|
Exhibit Number
|
Description
|
|
99.1
|
07 May
2025 - “EMTN programme publication of listing
particulars”
|
99.1
Haleon plc: EMTN programme publication of listing
particulars
07 May 2025: Haleon
plc (the "Company" or "Haleon") today announces that, following a
routine annual update, listing particulars dated 7 May 2025
regarding Haleon UK Capital plc's and Haleon Netherlands Capital
B.V.'s £10,000,000,000 Euro Medium Term Note ("EMTN")
Programme, guaranteed by the Company, have been published (the
"Listing Particulars").
A copy of the Listing Particulars is available for inspection at
and can be downloaded from
www.haleon.com/investors/debt-investors.
Amanda Mellor
Company Secretary
Enquiries
|
Investors
|
Media
|
||
|
Jo
Russell
|
+44
7787 392441
|
Zoë Bird
|
+44
7736 746167
|
|
Rakesh
Patel
|
+44
7552 484646
|
Victoria
Durman
|
+44 7894 505730
|
|
Emma
White
|
+44
7823 523562
|
|
|
|
Email: [email protected]
|
Email: [email protected]
|
||
About Haleon
Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with
a purpose to deliver better everyday health with humanity. Haleon's
product portfolio spans six major categories - Oral Health,
Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory
Health, Digestive Health, and Therapeutic Skin Health and Other.
Its long-standing brands - such as Advil, Centrum, Otrivin,
Panadol, parodontax, Polident, Sensodyne,
Theraflu and Voltaren - are built on trusted science, innovation
and deep human understanding.
For more information, please visit www.haleon.com.
Disclaimer
Please note that the information contained in the Listing
Particulars may be addressed to and/or targeted at persons who are
residents of particular countries (specified in the Listing
Particulars) only and is not intended for use and should not be
relied upon by any person outside these countries and/or to whom
the offer contained in the Listing Particulars is not addressed.
Prior to relying on the information contained in the Listing
Particulars, you must ascertain from the Listing Particulars
whether or not you are part of the intended addressees of the
information contained in the Listing Particulars.
Your right to access this service is conditional upon complying
with the above requirement.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
|
HALEON PLC
(Registrant)
|
|
|
Date: May 07,
2025
|
By:
|
/s/
Amanda Mellor
|
|
|
|
|
Name:
|
Amanda
Mellor
|
|
|
|
Title:
|
Company
Secretary
|